According to Zealand Pharma's latest financial reports the company has a price-to-book ratio of 22.8.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 13.7 | 97.43% |
2022-12-31 | 6.93 | 573.44% |
2021-12-31 | 1.03 | -12.84% |
2020-12-31 | 1.18 | 10.94% |
2019-12-31 | 1.06 | 206.28% |
2018-12-31 | 0.3474 | -57.04% |
2017-12-31 | 0.8086 | -42.01% |
2016-12-31 | 1.39 | |
2015-12-31 | N/A | -100% |
2014-12-31 | 1.21 | 55.17% |
2013-12-31 | 0.7817 | |
2012-12-31 | N/A | |
2011-12-31 | N/A | |
2010-12-31 | N/A |